Las Vegas, NV -- (SBWIRE) -- 12/24/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more. EquityObserver.com issues a special report on the following stocks: Synthetic Biologics Inc(NYSEMKT:SYN),Capstone Turbine Corporation(NASDAQ:CPST),Delcath Systems, Inc.(NASDAQ:DCTH),Rentech, Inc.(NASDAQ:RTK)
Synthetic Biologics Inc(NYSEMKT:SYN)managed to keep its gain at 18.10% on above-normal volume of 1.75Mshares. The stock settled at $1.37, after floating in a range of $1.20 - 1.45. Its latest price has reached market capitalization of $61.18M. Its 52-week range has been $0.95 - 2.10. Synthetic Biologics, Inc., formerly Adeona Pharmaceuticals, Inc.
How Should Investors Trade SYN Now?Don’t Miss out a Special Trend Analysis
Capstone Turbine Corporation(NASDAQ:CPST)trading on a volume of 1.91Mshares, lower than its standard daily volume. Shares have been closed at $1.24. Over the last twelve months, the stock has gained36.26% and faced a worst price of $0.73.Capstone Turbine Corporation (Capstone) develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications.
Is CPST a Solid Investment at These Levels?Read This Report for Details
Delcath Systems, Inc.(NASDAQ:DCTH)is up at $0.248 on below- normal volume of 1.71M shares during the last trading day. The stock has its 12-month range $0.22 - 2.19. Its Intraday range is $0.25 - 0.26.Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology.
How Should Investors Trade DCTH Now?Don’t Miss out a Special Trend Analysis
In the last trading day, Rentech, Inc.(NASDAQ:RTK) is on low volume, trading at a volume of versus its average daily volume ratio 2.12M/2.19M shares. At $1.68, the stock has attained market capitalization of 381.05M.Rentech, Inc. (Rentech) is a provider of clean energy solutions.
Will Investors Buy RTK After Reading This News?Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)